Literature DB >> 10541625

[Pathogenesis of diabetic foot disease].

E Chantelau1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10541625     DOI： 10.1007/s001080050429

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  4 in total

1.  Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.

Authors:  F J Legat; R Krause; P Zenahlik; C Hoffmann; S Scholz; W Salmhofer; J Tscherpel; T Tscherpel; H Kerl; P Dittrich
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  [Radiological and clinical aspects of diabetic-neuropathic osteoarthropathy].

Authors:  A Koller; J Fühner; H H Wetz
Journal:  Orthopade       Date:  2004-09       Impact factor: 1.087

Review 3.  [Diabetic complications. Micro and macroangiopathic end-organ damage].

Authors:  U D Lichtenauer; J Seissler; W A Scherbaum
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

4.  Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome.

Authors:  F J Legat; A Maier; P Dittrich; P Zenahlik; T Kern; S Nuhsbaumer; M Frossard; W Salmhofer; H Kerl; M Müller
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.